.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Accenture
US Department of Justice
Farmers Insurance
Daiichi Sankyo
Moodys
Express Scripts
AstraZeneca
Merck

Generated: June 28, 2017

DrugPatentWatch Database Preview

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Perphenazine And Amitriptyline Hydrochloride, and what generic Perphenazine And Amitriptyline Hydrochloride alternatives are available?

Perphenazine And Amitriptyline Hydrochloride is a drug marketed by Watson Labs, Par Pharm, Ivax Sub Teva Pharms, Mylan, Sandoz, and Sun Pharm Inds. and is included in thirty-five NDAs.

The generic ingredient in PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.

Summary for Tradename: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Patents:0
Applicants:6
NDAs:35
Suppliers / Packagers: see list1
Clinical Trials: see list104,480
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070375-001Aug 25, 1986DISCNNoNo► Subscribe► Subscribe
Par Pharm
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070565-001Sep 11, 1986DISCNNoNo► Subscribe► Subscribe
Watson Labs
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070376-001Aug 25, 1986DISCNNoNo► Subscribe► Subscribe
Watson Labs
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070373-001Aug 25, 1986DISCNNoNo► Subscribe► Subscribe
Watson Labs
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL073007-001Oct 17, 1991DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Fish and Richardson
AstraZeneca
Julphar
Federal Trade Commission
Accenture
Daiichi Sankyo
Mallinckrodt
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot